Highlands Oncology Group is a clinical research site located in Fayetteville, Arkansas, United States 72703.
Crixeo Clinical Trials Trust Score: 31/100 (FAILING). This profile has not yet been claimed by the site owner.
Highlands Oncology Group has participated in 115 clinical trials with 17 currently active.
Therapeutic areas: Neoplasms, Breast Neoplasms, Kidney Neoplasms.
Sponsors: Novartis Pharmaceuticals, Halozyme Therapeutics, Pfizer.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in Arkansas · View every site in Fayetteville
Trust Score: 31/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Highlands Oncology Group has a Crixeo Trust Score of 31/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Highlands Oncology Group has 115 clinical trials on record, with 17 currently active. Their work covers Neoplasms, Breast Neoplasms, Kidney Neoplasms.
Highlands Oncology Group has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.